Skip to main content

Industries

EfTEN United Property Fund erhöht Beteiligung am Einkaufszentrum Domina in Riga auf 5,9%

EfTEN United Property Fund investiert 2,478 Mio. EUR in Einkaufszentrum Domina in Riga

Der EfTEN United Property Fund erwirbt für 2,478 Millionen Euro einen weiteren Anteil an der SIA EfTEN Domina, der Eigentümergesellschaft des Domina-Einkaufszentrums in Riga. Durch diese Transaktion steigt die Beteiligung des Fonds auf 5,9% des Unternehmenskapitals.

Details zur Transaktion

Bisher hielt der Fonds über die EfTEN Kinnisvarafond II AS eine indirekte Beteiligung von 0,71% (entspricht 380.000 EUR) am Domina-Zentrum. Der Abschluss der aktuellen Transaktion wird bis Ende August erwartet. Infolge dieses Erwerbs erhöht sich der Anteil von Einzelhandelsimmobilien im Portfolio des Fonds um 7 Prozentpunkte auf insgesamt 47%.

Über das Domina-Einkaufszentrum

Das Domina-Einkaufszentrum zählt zu den größten Shopping- und Freizeitzentren in Riga. Es verfügt über:

EfTEN United Property Fund investeerib 2,478 miljonit eurot Riia Domina kaubanduskeskusesse

EfTEN United Property Fund suurendab osalust Riia Domina kaubanduskeskuses

EfTEN United Property Fund investeerib 2,478 miljonit eurot osaluse omandamiseks ettevõttes SIA EfTEN Domina, mis omab Riias asuvat Domina kaubanduskeskust. Fond omandab ettevõttes 5,9% suuruse osaluse. Varem omas fond Domina keskuses kaudselt 0,71% (ligikaudu 380 tuhande euro) suurust positsiooni läbi EfTEN Kinnisvarafond II AS-i. Tehing on kavas lõpule viia augusti lõpuks. Tehingu tulemusena suureneb kaubanduskinnisvara osakaal fondi portfellis 7 protsendipunkti võrra (47%-le).

Philips Wins FDA Clearance for Reusable SpO₂ Sensor Built to Hold Accuracy Across Skin Tones

Image
Philips Wins FDA Clearance for Reusable SpO₂ Sensor Built to Hold Accuracy Across Skin Tones

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor, a pulse oximetry device built around internal optical refinements that improve signal quality. In desaturation testing, the sensor posted an accuracy result nearly twice as tight as the level recommended by ISO and recognized by the FDA. It also held accuracy within half a percentage point between light and dark skin pigmentation groups tested. The clearance extends Philips' broader pulse oximetry portfolio and follows a validation program built specifically around performance across diverse patient populations.

Philips Adds Alturion to Ultrasound Line, Targets High-Volume Clinical Workflows

Image
Philips Adds Alturion to Ultrasound Line, Targets High-Volume Clinical Workflows

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has launched Alturion, a new ultrasound system built for departments that run high patient volumes across varied exam types. The system pairs AI-powered workflow tools with imaging hardware designed to hold up across shift changes and multiple users. Alturion has received FDA 510(k) clearance and CE mark certification, making it available now in the U.S. and Europe. Philips positions the launch as an expansion of its ultrasound portfolio rather than a standalone product, built to share transducers and interface design with existing systems already in clinical use.

HD Advanced Technologies and PHENOGY Build Sodium-Ion Battery Manufacturing Base in Germany

Image
HD Advanced Technologies and PHENOGY Build Sodium-Ion Battery Manufacturing Base in Germany

SHERIDAN, WYOMING -- July 22, 2026 -- HD Advanced Technologies GmbH (HDAT), a wholly owned subsidiary of Heidelberger Druckmaschinen AG (HEIDELBERG), has signed a two-part industrial partnership with Swiss battery developer PHENOGY AG. HDAT will take over contract manufacturing of PHENOGY's sodium-ion energy storage systems, covering everything from procurement to installation and maintenance. The two companies are also preparing a joint venture to develop and mass-produce sodium-ion battery cells, combining PHENOGY's cell chemistry with a HEIDELBERG printing process. The goal is a European-based supply chain for battery storage that does not depend on manufacturing capacity outside the region.

HEIDELBERG Adds ChromaStar Dispensing Line to Cut Spot Color Bottlenecks in Packaging Printing

Image
HEIDELBERG Adds ChromaStar Dispensing Line to Cut Spot Color Bottlenecks in Packaging Printing

SHERIDAN, WYOMING -- July 22, 2026 -- Heidelberger Druckmaschinen AG (HEIDELBERG) has introduced the ChromaStar series, a modular ink dispensing platform built to automate spot color production directly inside print shops. The system targets a persistent operational problem in packaging printing: manual, unstandardized spot color mixing that slows turnaround and ties up skilled staff. Four models — X, S, M, and P — scale from entry-level manual batch preparation to fully automated, high-volume industrial dispensing. HEIDELBERG frames the launch as an expansion of its Lifecycle consumables business and its role as a system integrator for packaging printers.

AI-Readable Earnings Disclosures Become a New Investor Relations Discipline

SHERIDAN, WYOMING -- July 12, 2026 -- ACCESS Newswire is urging investor relations teams to treat artificial intelligence systems as a new audience for earnings communications. The company says disclosures now need to be structured so AI assistants can accurately retrieve, summarize, and compare financial results, guidance, and KPI definitions. For public companies, the issue is operational as much as technological: inconsistent wording, image-based tables, and delayed transcripts can shape how investors receive earnings information through AI tools. ACCESS Newswire frames this shift as a discipline sitting alongside traditional earnings releases, investor calls, and regulatory disclosure controls. ##### **AI assistants now shape how investors encounter earnings information** Investors and analysts increasingly begin research by asking AI assistants questions about company performance, guidance, and quarter-over-quarter trends.

Tianjin University Thermal-Pulse Process Cuts Platinum Catalyst Synthesis Time and Energy

SHERIDAN, WYOMING -- July 12, 2026 -- A research team at Tianjin University has reported a new catalyst synthesis method in *Science* that uses millisecond-scale thermal pulses to assemble platinum-group catalysts with tighter structural control. The study, published July 10, 2026, describes a transient assembly strategy for platinum-rich core-shell catalysts used in hydrogen fuel cells and other clean-energy applications. For industrial catalyst developers, the work offers a potentially faster route to high-activity materials while lowering energy demand and reducing reliance on hazardous synthesis inputs. ##### **Millisecond thermal pulses replace prolonged high-temperature annealing** Tianjin University researchers and collaborators developed a non-equilibrium transient assembly process that delivers heat in short, periodic pulses.

Rosen Law Reminds Genius Group Investors of August 28 Lead Plaintiff Deadline

SHERIDAN, WYOMING -- July 12, 2026 -- The Rosen Law Firm, P.A. is reminding purchasers or sellers of Genius Group Limited securities that the deadline to seek appointment as lead plaintiff in an already filed class action is August 28, 2026. The notice covers investors who traded Genius Group Limited securities, listed on NYSE American under the ticker GNS, during the April 12, 2022 to May 30, 2025 class period. The litigation alleges spoofing and other market conduct tied to Genius securities, with Rosen Law seeking investors who may want a representative role in directing the case. The firm says eligible investors may pursue claims under a contingency fee arrangement without out-of-pocket fees or costs. ##### **The lead plaintiff deadline creates a defined decision point for affected investors** Rosen Law says investors who bought or sold Genius Group Limited securities during the stated class period may be entitled to seek compensation in the litigation.

Corgi Insurance Adds Veteran Executive Rob Barlow to Support Community Association Expansion

SHERIDAN, WYOMING -- July 12, 2026 -- Corgi Insurance announced the addition of Robert E. “Rob” Barlow Jr., a specialty insurance executive with more than 30 years of leadership experience, to support continued expansion across community association, condominium, homeowners association, and broader property and casualty markets. Barlow’s background in habitational and association-focused programs gives Corgi a senior commercial insurance leader with direct experience in broker-facing operations, program development, and national sales execution.

Tianjin University team uses millisecond thermal pulses to accelerate platinum catalyst synthesis

SHERIDAN, WYOMING -- July 12, 2026 -- A Tianjin University research team has published research in *Science* describing a millisecond-scale thermal pulse method for producing platinum-group catalysts with tighter structural control. The study, released July 10, 2026, centers on a transient assembly strategy for platinum-skin intermetallic catalysts used in hydrogen fuel cells. According to the university, the approach shortens catalyst production from hours to minutes, reduces synthesis energy use by 90 percent and produces a three-atomic-layer platinum shell.

Artikel (Parse‑Fehler)

{ "ai_generated_title": "Primis Financial Corp. Sets Q2 2026 Earnings Release and Conference Call", "body_html": "

SHERIDAN, WYOMING -- July 11, 2026 -- Primis Financial Corp. (NASDAQ: FRST) has scheduled its second quarter 2026 earnings release for after the market closes on Thursday, July 23, 2026. The McLean, Virginia-based company said it will follow the release with a conference call and audio webcast for analysts and investors at 10:00 a.m. Eastern Time on Friday, July 24. The announcement gives B2B stakeholders a clear timetable for reviewing the company’s next quarterly disclosure and for preparing questions around its reported balance sheet, lending activity, deposit base and digital service footprint. Primis disclosed that, as of March 31, 2026, it had $4.3 billion in total assets, $3.4 billion in loans held for investment and $3.4 billion in deposits.

Biogena Founder Discusses Preventive Health Market Growth and Planned Vienna Stock Exchange Listing

SHERIDAN, WYOMING -- July 10, 2026 -- Biogena founder and CEO Dr. Albert Schmidbauer outlined the strategic rationale behind his company's planned stock market listing in a recent podcast interview, positioning preventive health as a major European growth sector. The Salzburg-based micronutrient and preventive health company aims to raise up to 25 million euros through its listing on the Vienna Stock Exchange Direct Market Plus. Schmidbauer discussed the company's evolution from a niche market pioneer to an international health brand serving approximately one million customers across 70 countries.

Entain Welcomes German Regulatory Adjustment to Virtual Slot Machine Stake Limits Effective July 2026

SHERIDAN, WYOMING -- July 10, 2026 -- Entain plc, parent company of sports betting brand bwin and one of the world's largest online sports betting and gaming operators, has welcomed a regulatory decision by Germany's Joint Gaming Authority (GGL) to raise stake limits for virtual slot machine games. The adjustment takes effect July 1, 2026, following approval by state representatives on the GGL's administrative council. The change allows maximum stakes of three or five euros per game depending on individual player qualifications, replacing the previous one-euro limit established under Germany's Interstate Treaty on Gambling.

Vancouver Cybersecurity Firm Quantum Secure Encryption Expands QAuth Identity Platform Into Indonesia and Malaysia

SHERIDAN, WYOMING -- July 10, 2026 -- Quantum Secure Encryption Corp. (CSE: QSE) (OTCQB: QSEGF) (FSE: VN80), a Vancouver-based post-quantum cybersecurity company, announced a partner-led sales and channel initiative for QAuth, its quantum-ready identity and authentication platform, across Indonesia and Malaysia. The expansion targets enterprise, government and regulated-industry buyers in financial services, healthcare, telecommunications, manufacturing and critical infrastructure sectors. QSE positions the rollout as a strategic entry into two of Southeast Asia's fastest-growing cybersecurity markets, where digital transformation and regulatory requirements are driving demand for modernized authentication and access control.

Nootropics Depot CEO Proposes Bioactive-First Framework for Reishi Mushroom Quality Standards

SHERIDAN, WYOMING -- July 10, 2026 -- Nootropics Depot released a white paper challenging conventional Reishi mushroom quality standards and proposing a new framework centered on bioactive compound groups rather than single marker molecules. CEO Paul Eftang authored the paper, titled "Beyond the Marker: A Bioactives-First Standard for Reishi Quality," which argues that current industry practices prioritize measurement convenience over functional relevance. The company announced the publication on July 9, 2026, positioning the framework as a practical tool for laboratories, manufacturers, and quality assurance teams evaluating mushroom extracts.

MSP360 RMM Launches Public API for Direct Integration with Dashboards, PSA Systems, and BI Tools

SHERIDAN, WYOMING -- July 10, 2026 -- MSP360, a provider of backup, RMM, and remote access software for managed service providers, has released a public API for MSP360 RMM that enables external platforms to access endpoint data directly. The API provides read-only access to RMM data, allowing MSPs to connect MSP360 RMM to existing dashboards, PSA systems, and business intelligence tools without manual data transfers. The release addresses operational inefficiencies that forced mid-sized and larger MSPs to either split visibility across multiple consoles or allocate staff time to manual data export and import workflows.

German Parliament Exempts Blood Plasma Products from Additional Manufacturer Surcharge Under Healthcare Stabilization Law

SHERIDAN, WYOMING -- July 10, 2026 -- The German Bundestag has passed the Healthcare Contribution Rate Stabilization Act, exempting supply-critical active pharmaceutical ingredients from an additional 8.5 percent manufacturer surcharge. The Plasma Protein Therapeutics Association Deutschland e.V. (PPTA) welcomed the legislative decision, which recognizes the unique production and supply realities of blood plasma products essential for patients with severe and rare diseases. The exemption addresses operational concerns about maintaining access to medications that cannot be synthetically manufactured and require seven to twelve months from donation to finished product.